Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
Various biotech firms
|
| gptkbp:awards |
gptkb:National_Science_and_Technology_Progress_Award
gptkb:China_Patent_Award Global Health Award |
| gptkbp:clinical_trial |
Phase III Trials
Post-Marketing Surveillance Vaccine Efficacy Studies Multiple Vaccine Candidates Safety Trials |
| gptkbp:collaboration |
International Organizations
|
| gptkbp:collaborations |
Global Universities
|
| gptkbp:community_engagement |
Health Education Programs
Vaccination Campaigns Public Awareness Initiatives |
| gptkbp:employees |
Over 10,000
|
| gptkbp:financial_support |
Research Grants
Healthcare Initiatives Public Health Projects |
| gptkbp:focus |
Vaccine Development
|
| gptkbp:founded |
gptkb:2003
|
| gptkbp:future_plans |
Strengthen Partnerships
Increase Global Reach Enhance R& D Capabilities Expand Vaccine Portfolio Invest in Biotech Innovations |
| gptkbp:headquarters |
gptkb:Beijing,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sinopharm Technology
|
| gptkbp:innovation |
Vaccine Technology
|
| gptkbp:involved_technology |
Research Institutions
Developing Countries Local Manufacturers |
| gptkbp:market |
Global
|
| gptkbp:market_position |
gptkb:Africa
gptkb:Europe gptkb:Middle_East gptkb:Asia Americas |
| gptkbp:notable_products |
BBIBP-Cor V
WIBP-Cor V |
| gptkbp:parent_company |
gptkb:China_National_Pharmaceutical_Group
|
| gptkbp:partnership |
gptkb:World_Health_Organization
Research Institutions Local Governments |
| gptkbp:product_type |
Vaccines
Biopharmaceuticals |
| gptkbp:regulatory_compliance |
Various Countries
|
| gptkbp:research_focus |
Infectious Diseases
|
| gptkbp:revenue |
Billions USD
|
| gptkbp:subsidiary |
Sinopharm Vaccine
|
| gptkbp:sustainability_initiatives |
Environmental Protection
Community Health Programs Green Manufacturing |
| gptkbp:bfsParent |
gptkb:China_National_Pharmaceutical_Group_Corporation
|
| gptkbp:bfsLayer |
5
|